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In this month’s SAMJ, Millard et al.[1] report the 
results of an innovative study comparing surgical 
circumcision to that using a Unicirc device plus tissue 
adhesive. This is a follow-up to their earlier study 
using a similar non-disposable device (Gomco)[2] This 
study is timely because South Africa (SA) is not on target to meet its 
planned objective of circumcising 80% of men between the ages of 
15 and 49 or 4.3 million by 2015[3] and points the way toward a faster, 
easier method that may aid in voluntary medical male circumcision 
(VMMC) scale-up in areas of Africa with a high prevalence of HIV 
infection.
Three landmark randomised trials carried out in SA, Kenya, and 
Uganda were published in 2007.[4-6] The trials were all terminated 
early based on interim analyses that showed a significantly lower 
rate of newly-acquired HIV infection for the circumcised v. the 
uncircumcised men. These 3 studies later formed the basis of a 
Cochrane review, which confirmed the value of surgical circumcision 
with healing by primary intention as a method for preventing 
heterosexual HIV transmission. The combined results showed that 
VMMC reduced incident HIV infection rates by 60%. Some people 
dismiss circumcision as a beneficial, preventive intervention, claiming 
that it encourages men to participate in unprotected sexual activity. 
The truth is that despite counselling and increased knowledge, the 
use of condoms remains sporadic among men. The differences 
between the control and circumcised groups would not have become 
apparent so quickly if the men had been using condoms as advised.
Based on this strong scientific evidence, VMMC is a priority 
intervention for the World Health Organization (WHO) and the 
President’s Emergency Plan for AIDS Relief (PEPFAR). Circumcised 
men have a lower risk of acquiring HIV because, following 
circumcision, the epithelium of the glans penis becomes keratinised, 
and keratinised epithelium is largely resistant to the passage of HIV-
infected T-cells.
Uncircumcised men, on the other hand, are at higher risk of HIV 
acquisition because the inner foreskin layer allows HIV -infected cells to 
form apical viral synapses with the dendrites of Langerhans cells present 
on the moist mucosal surface of the glans and inner part of the prepuce. [7] 
Infected T-cells pass through the epithelial layer and attach to the 
dendrites of the Langerhans cells. The inner foreskin produces tumour 
necrosis factor, which stimulates the Langerhans cells via cytokines 
to produce an influx of CD4+ T-cells. The Langerhans cells produce 
langerin, which binds HIV and helps the cells degrade it and transport 
the virus to local lymph nodes.
The WHO Global Health sector Strategy on HIV/AIDS for 2011 
- 2015 has determined that scale-up of VMMC in Africa constitutes 
a high-impact, cost-effective intervention. They suggest scaling-up 
medical male circumcision to 80% coverage for 15- to 49-year-old 
males in 14 priority countries in sub-Saharan Africa by 2015. This 
will require 20.5 million circumcisions, and is expected to avert 
3.4 million new HIV infections by 2025. It will cost US$1.5 billion, 
but save US$16.5 billion of healthcare costs.
Each of the large African studies used an open surgical method 
of circumcision. Surgical circumcision has several disadvantages 
for scaling-up and reaching the above-mentioned ambitious 
targets: it requires a high level of surgical skill, is time-consuming 
(approximately 20 min/procedure) and is costly. Given these 
disadvantages of surgical circumcision, WHO has requested that 
new, more cost-effective techniques be developed to facilitate scale-
up, which is already well behind schedule in most African countries 
with a high prevalence of HIV.
There are many different circumcision techniques. Development 
of clamps and rings for circumcision using modern materials began 
in the 1930s. One of the earlier prototypes came from the Goldstein 
Medical Company (Gomco). These older instruments allow the 
circumciser to remove almost the entire inner foreskin. 
Recently, several disposable plastic devices have been developed. 
The new plastic ring devices are left in place for 1 week, and then 
removed in the clinic. The unpleasantness of wearing a plastic ring 
on the penis for a week, the smell of necrotic material, and the 
return visit for removal of the device negate many of the benefits. 
Because healing is by secondary intention, the delayed healing 
may facilitate new infections if sexual activity is not delayed for 
up to 6 weeks postoperatively.
The approach by Millard et al.[2] using the Gomco device, 
while avoiding the problems of healing by secondary intention, 
provided other problems in keeping with the use of a non-
disposable device. The single-use disposable Unicirc device[1] 
also works by clamping the the foreskin, removing it and sealing 
the wound with cyanoacrylate tissue adhesive avoiding the use 
of sutures. This novel technique is much faster, simpler to learn, 
nearly bloodless and heals rapidly by first intention. Circumcision 
with the Unicirc device is 30 - 40% faster than using standard 
surgical methods. Adverse events were similar to those of the 
surgical control group. The intraoperative suture rate for the 
Unicirc was 17% initially due to the utilisation of inadequate tissue 
pressure. This rate should come down as the newer modifications 
of this device generate more tissue compressibility.
This device meets all the WHO criteria of a disposable, single-
use device to prevent cross-contamination, as occurred in the 
early phases of the HIV epidemic.
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